Frontlight ResearchEarly access
Trial site
OU Medical Center
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Stroke2 trials
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- University of Florida1 trial
- Yale University1 trial
Running trials
Active, not recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Bladder cancer1 recruiting
- Stroke1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026